Multi-annual Programme on Life Sciences & Health
The United States (US) has the highest healthcare expenditure in the world, creating major opportunities for Dutch Life Sciences & Health (LSH) companies. In addition, its robust investment landscape makes it an attractive market for innovative medical technologies.
With its market size, growth potential, and investment readiness, the US offers Dutch LSH organisations unique opportunities for expansion, collaboration, research, and innovation.
Through the Strategic Multi-Annual Market (SMM) Approach LSH US, you can stay informed about key developments, build sustainable research collaborations, and strengthen your position in the US healthcare market.
Event Details
United States – Netherlands | SMM Life Sciences & Health
1 January 2025
–
31 December 2027
United States, North America
What is the SMM LSH United States?
The SMM LSH US is a Strategic Multi-Annual Market (SMM) approach coordinated by the Netherlands Enterprise Agency (RVO) and Task Force Health Care (TFHC). This public–private initiative aims to strengthen the position of Dutch LSH companies in the digital health and MedTech sectors.
The programme focuses on Texas and California, where strong existing connections and collaborations provide a solid foundation for deepening partnerships and scaling Dutch LSH organisations in the US.
From December 2024 to December 2027, a wide range of activities will be organised to support Dutch LSH organisations with market entry and scale-up opportunities in the United States.
How This Event Supports Your Growth
The overall objective of the SMM programme is to strengthen the competitive position of the LSH sector in the US and to reinforce the Netherlands’ role as one of the world’s leading LSH hubs.
To achieve this, an action plan has been developed in close collaboration with the Dutch LSH sector. The plan includes a series of complementary activities designed to:
• Enhancing the international positioning of the Dutch LSH sector
• Driving economic growth and attracting foreign direct investment
• Strengthening research and development collaboration
Activities and Relevant Information 2025
Activities include workshops and expert sessions, as well as outgoing and incoming missions, to support Dutch LSH organisations in establishing sustainable collaborations and gaining relevant, up-to-date market and segment information
- Los Angeles, United States – Life Sciences & Health Mission | 3-7 February
Are you interested in the trends, developments, and opportunities in the LSH sector, specifically in Los Angeles? Then join our LSH mission to Los Angeles. During this visit, participants will meet with a variety of stakeholders, including private hospitals and leading health networks. This mission is designed for Dutch LSH organisations that are active in the digital health, MedTech, and telemedicine sectors and are committed to expanding their presence in the US market. Registration for this mission closed on Friday, 6 December 2024. - The Hague, The Netherlands – USA Expert Session | 7 May
The US presents significant opportunities for research, innovation, and expansion among Dutch LSH companies. Collaboration between the Netherlands and the US delivers unmatched value by leveraging complementary strengths to drive innovation. However, the recent transition to a new Trump administration may bring policy shifts and reshape the business landscape. Join us for the US Expert Session to gain valuable insights into these emerging challenges and opportunities.
- Amsterdam, The Netherlands – Incoming visit from the United States | 16 – 19 June
The Netherlands is quickly becoming the epicentre of global health innovation, and from 16 to 19 June, HLTH Europe will further strengthen that reputation. With more than 5,000 attendees from over 50 countries, HLTH Europe offers Dutch health tech companies the perfect opportunity to expand their networks and connect with health providers, payers, investors, and government stakeholders from around the world. The NL Pavilion – The Dutch Innovator Village, at HLTH Europe serves as a launchpad for Dutch startups and scaleups to showcase their innovations. During the event, we also hosted an incoming delegation that included representatives from the Texas Medical Center (TMC) and Cedars-Sinai.
- Texas, United States – Life Sciences & Health Mission | 6-10 October 2025
Texas offers a dynamic ecosystem for MedTech and digital health innovation, making it an ideal hub for Dutch LSH companies seeking to expand. Our upcoming LSH mission to Texas will explore the state’s unique opportunities, with a focus on Houston and Austin. Are you looking for expert insights, resources, and high-level networking in the LSH sector? Join us on this mission and discover what Texas has to offer.
Interested in Joining this Programme?
Would you like to receive updates on the activities of the SMM LSH United States programme? Please let us know by completing the registration form below. Once registered, you will automatically receive updates.
"*" indicates required fields
Event Details
United States – Netherlands | SMM Life Sciences & Health
1 January 2025
–
31 December 2027
United States, North America
In Collaboration With
Ukraine
